Efficacy And Safety Of Glycopyrronium In COPD Patients With Moderate-To-Severe Airflow Limitation: The Gem1 Study

被引：0
|
作者：
LaForce, C. [1 ]
Pearle, J. [2 ]
Feldman, G. [3 ]
Spangenthal, S. [4 ]
Eckert, J. H. [5 ]
Mota, F. [5 ]
Henley, M. [6 ]
D'Andrea, P. [6 ]
机构：
[1] North Carolina Clin Res, Raleigh, NC USA
[2] Calif Res Med Grp Inc, Fullerton, CA USA
[3] S Carolina Pharmaceut Res, Spartanburg, SC USA
[4] Amer Hlth Res Charlotte, Charlotte, NC USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5745
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of ustekinumab in the treatment of patients affected by moderate-to-severe psoriasis
    Talamonti, M.
    Galluzzo, M.
    Teoli, M.
    Bavetta, M.
    Chimenti, S.
    Costanzo, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (06) : E34 - E34
  • [42] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Eichenfield, L. F.
    Blauvelt, A.
    Rosmarin, D.
    Hussain, I.
    Davis, J. D.
    Li, M.
    Zhang, Q.
    Gadkari, A.
    Eckert, L.
    Kamal, M. A.
    Bansal, A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
  • [43] Efficacy and safety of infliximab biosimilars in the treatment of patients with moderate-to-severe psoriasis
    Chasapi, Vasiliki
    Routsi, Eleni
    Lantzou, Sotiria
    Papoutsaki, Marina
    Panagakis, Pantelis
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [44] Efficacy And Safety Of Qva149 Versus Glycopyrronium And Tiotropium In A Subgroup Of Patients With Severe COPD: The Spark Study
    Wedzicha, J.
    D'Urzo, A. D.
    Decramer, M.
    Ficker, J. H.
    Sandstrom, T.
    Taylor, A. Fowler
    D'Andrea, P.
    Mezzi, K.
    Chen, H.
    Banerji, D.
    Fogel, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [45] Poor perception of airflow limitation in patients with moderate to severe asthma
    Souza-Machado, A
    Cavalcante, M
    Cruz, AA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S190 - S190
  • [46] Importance Of Symptomatic Assessment In COPD Patients With Mild To Moderate Airflow Limitation
    Hwang, Y.
    Kim, J.
    Park, S.
    Lee, C.
    Park, S.
    Park, Y.
    Jang, S.
    Kim, C.
    Kim, D. -G.
    Lee, M.
    Hyun, I. -G.
    Jung, K. -S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [47] EVALUATION OF EFFICACY AND SAFETY OF SWITCHING TO QVA149 FROM SALMETEROL/FLUTICASONE IN SYMPTOMATIC PATIENTS WITH MODERATE-TO-SEVERE COPD: THE FLASH STUDY
    Frith, Peter
    Riachy, Moussa
    Ditommaso, Shelley
    Fogel, Robert
    Pilipovic, Virginia
    RESPIROLOGY, 2015, 20 : 39 - 39
  • [48] EFFICACY AND SAFETY OF IND/GLY VERSUS PLACEBO AND TIOTROPIUM IN SYMPTOMATIC PATIENTS WITH MODERATE-TO-SEVERE COPD: THE 52-WEEK RADIATE STUDY
    Larbig, Michael
    Fowlertaylor, Angel
    Maitra, Samopriyo
    Schubert-Tennigkeit, Agnes
    Banerji, Donald
    RESPIROLOGY, 2015, 20 : 44 - 44
  • [49] Efficacy and Safety of Ivarmacitinib in Patients With Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study
    Chen, Baili
    Zhong, Jie
    Li, Xiuling
    Pan, Feng
    Ding, Yijuan
    Zhang, Yan
    Chen, Hong
    Liu, Fei
    Zhang, Zhenyu
    Zhang, Ling
    Drozda, Rafal
    Oliinyk, Oleksandr
    Goh, Aik Han
    Chen, Xiang
    Sun, Xiang
    Rubin, David T.
    Sandborn, William J.
    Chen, Minhu
    GASTROENTEROLOGY, 2022, 163 (06) : 1555 - 1568
  • [50] Evaluation of Glycopyrronium Therapy in Chinese Patients Versus Predominantly Caucasian Populations in Patients With Moderate-to-Severe COPD: Comparison of Clinical Data
    Wang, Chen
    Sun, Tieying
    Huang, Yijiang
    Humphries, Michael
    Bai, Lingyan
    Li, Lilly
    Wang, Qian
    Lin, Zi
    D'Andrea, Peter
    Altman, Pablo
    CHEST, 2016, 149 (04) : 390A - 390A
12345